These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21889335)

  • 1. Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. Part 2: Synthesis of novel triplet drugs with the epoxymethano structure (capped homotriplet).
    Nagase H; Koyano K; Wada N; Hirayama S; Watanabe A; Nemoto T; Nakajima M; Nakao K; Mochizuki H; Fujii H
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6198-202. PubMed ID: 21889335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. 1: Synthesis of triplet drugs with morphinan skeletons.
    Nagase H; Watanabe A; Nemoto T; Nakajima M; Hasebe K; Mochizuki H; Fujii H
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4023-6. PubMed ID: 21641219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. 3: synthesis of novel triplet drugs with the bis(epoxymethano) or bis(dimethylepoxymethano) structure (double-capped triplet).
    Wada N; Fujii H; Koyano K; Hirayama S; Iwai T; Nemoto T; Nagase H
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7551-4. PubMed ID: 23131341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: part 3, novel propellane derivatives with pentacyclic skeletons.
    Fujii H; Nakajima R; Akiyama J; Yamamoto N; Hirayama S; Nemoto T; Gouda H; Hirono S; Nagase H
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7697-701. PubMed ID: 23116891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology: part 1.
    Yamamoto N; Fujii H; Nemoto T; Nakajima R; Momen S; Izumimoto N; Hasebe K; Mochizuki H; Nagase H
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4104-7. PubMed ID: 21641798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel triplets with a 1,3,5-trioxazatriquinane skeleton and their pharmacologies for opioid receptors.
    Nagase H; Kutsumura N
    Arch Pharm (Weinheim); 2015 Jun; 348(6):375-89. PubMed ID: 25964204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology. Part 2: Propellane derivatives with an amide side chain.
    Nagase H; Akiyama J; Nakajima R; Hirayama S; Nemoto T; Gouda H; Hirono S; Fujii H
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2775-9. PubMed ID: 22460026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.
    Husbands SM; Neilan CL; Broadbear J; Grundt P; Breeden S; Aceto MD; Woods JH; Lewis JW; Traynor JR
    Eur J Pharmacol; 2005 Feb; 509(2-3):117-25. PubMed ID: 15733546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of iboga-like isoquinuclidines: Dual opioid receptors agonists having antinociceptive properties.
    Banerjee TS; Paul S; Sinha S; Das S
    Bioorg Med Chem; 2014 Nov; 22(21):6062-70. PubMed ID: 25281271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid binding and in vitro profiles of a series of 4-hdroxy-3-methoxyindolomorphinans. Transformation of a delta-selective ligand into a high affinity kappa-selective ligand by introduction of a 5,14-substituted bridge.
    Grundt P; Martinez-Bermejo F; Lewis JW; Husbands SM
    J Med Chem; 2003 Jul; 46(14):3174-7. PubMed ID: 12825957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of the gerbil writhing response by mu-, kappa- and delta-opioids, and NK-1, -2 and -3 receptor antagonists.
    Gallantine EL; Meert TF
    Pharmacol Biochem Behav; 2004 Sep; 79(1):125-35. PubMed ID: 15388292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chain.
    Nakajima R; Yamamoto N; Hirayama S; Iwai T; Saitoh A; Nagumo Y; Fujii H; Nagase H
    Bioorg Med Chem; 2015 Oct; 23(19):6271-9. PubMed ID: 26346669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton and their pharmacologies.
    Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Nagase H
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2689-92. PubMed ID: 22445285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton having a 7-amide side chain and their pharmacologies.
    Watanabe Y; Kitazawa S; Nemoto T; Hirayama S; Iwai T; Fujii H; Nagase H
    Bioorg Med Chem; 2013 Jun; 21(11):3032-50. PubMed ID: 23623711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors.
    Eans SO; Ganno ML; Mizrachi E; Houghten RA; Dooley CT; McLaughlin JP; Nefzi A
    J Med Chem; 2015 Jun; 58(12):4905-17. PubMed ID: 25996309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives.
    Franchini S; Battisti UM; Prandi A; Tait A; Borsari C; Cichero E; Fossa P; Cilia A; Prezzavento O; Ronsisvalle S; Aricò G; Parenti C; Brasili L
    Eur J Med Chem; 2016 Apr; 112():1-19. PubMed ID: 26874044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime.
    Spetea M; Schüllner F; Moisa RC; Berzetei-Gurske IP; Schraml B; Dörfler C; Aceto MD; Harris LS; Coop A; Schmidhammer H
    J Med Chem; 2004 Jun; 47(12):3242-7. PubMed ID: 15163203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.